Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 16.20% is 42% above its 5-year average of 11.44%, near the high end of its 5-year range (5.71%–17.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.12% above its 12-month average of 15.27%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.20%.
DEBT TO ASSETS RATIO
16.20%
DEBT TO ASSETS RATIO AVG TTM
15.27%
DEBT TO ASSETS RATIO AVG 3Y
13.67%
DEBT TO ASSETS RATIO AVG 5Y
11.44%
DEBT TO ASSETS RATIO AVG 10Y
8.69%
DEBT TO ASSETS RATIO AVG 15Y
5.64%
DEBT TO ASSETS RATIO AVG 20Y
5.66%
CURRENT VS TTM AVG
+6.12%
CURRENT VS 3Y AVG
+18.49%
CURRENT VS 5Y AVG
+41.60%
CURRENT VS 10Y AVG
+86.40%
CURRENT VS 15Y AVG
+187.15%
CURRENT VS 20Y AVG
+186.50%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 705 covered companies
CURRENT VS SECTOR MEDIAN
+16101.80%
vs the sector median at left
Inovio Pharmaceuticals, Inc.
Market Cap
$79.46M
Debt to Assets Ratio
16.20%
TTM Avg
15.27%
3Y Avg
13.67%
5Y Avg
11.44%
Market Cap
$80.30M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.80M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.04M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.46M | 16.20% | 15.27% | 13.67% | 11.44% |
| Pulmonx Corporation (LUNG)vs › | $80.01M | 0.49% | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $80.30M | 0.09% | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | 0.06% | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.65M | 0.21% | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.56M | 0.43% | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.66M | 0.03% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | 0.02% | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 0.00% | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $83.21M | 0.03% | N/A | N/A | N/A |
Debt/Assets
16.2%
Debt/Equity
1.83
Current Ratio
1.00
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 16.20% |
| 2026-03-31 | 17.47% |
| 2025-12-31 | 12.61% |
| 2025-09-30 | 14.44% |
| 2025-06-30 | 15.62% |
| 2025-03-31 | 12.91% |
| 2024-12-31 | 10.48% |
| 2024-09-30 | 11.62% |
| 2024-06-30 | 9.70% |
| 2024-03-31 | 10.40% |
| 2023-12-31 | 17.67% |
| 2023-09-30 | 15.43% |
| 2023-06-30 | 13.20% |
| 2023-03-31 | 11.69% |
| 2022-12-31 | 9.20% |
| 2022-09-30 | 8.27% |
| 2022-06-30 | 7.25% |
| 2022-03-31 | 7.55% |
| 2021-12-31 | 6.66% |
| 2021-09-30 | 6.19% |
| 2021-06-30 | 5.71% |
| 2021-03-31 | 5.18% |
| 2020-12-31 | 7.23% |
| 2020-09-30 | 17.04% |
| 2020-06-30 | 22.80% |
| 2020-03-31 | 29.07% |
| 2019-12-31 | 69.13% |
| 2019-09-30 | 61.40% |
| 2019-06-30 | 52.21% |
| 2019-03-31 | 44.17% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 1.68% |
| 2010-03-31 | 15.17% |
| 2009-12-31 | 15.03% |
| 2009-09-30 | 13.39% |
| 2009-06-30 | 26.06% |
| 2009-03-31 | 33.55% |
| 2008-12-31 | 31.06% |
| 2008-09-30 | 5.79% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 2.04% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.01% |
| 2002-12-31 | 0.38% |
| 2002-09-30 | 0.39% |
